ThursdayOct 14, 2021 2:00 pm

Shining the Spotlight on Binge-Eating Disorder

Research shows that binge-eating disorder, which is more common than other eating disorders such as bulimia and anorexia, affects more women than men. Experts say that despite popular opinion that binge eating is a mood or phase, it is a serious issue that needs to be addressed. Regence BlueCross BlueShield’s executive medical director Dr. Amy Khan states that eating disorders often represent serious mental health conditions. Khan explains that eating disorders are serious ailments that can impact an individual’s social, emotional and physical functioning. This is in addition to affecting their cardiovascular health and causing gastrointestinal issues. The disorders are…

Continue Reading

WednesdayOct 13, 2021 11:38 am

Second-, Third-Degree Relatives of Colon Cancer Patients at Risk of Developing the Ailment

A new study has discovered that having relatives who have colorectal cancer heightens an individual’s risk of developing this ailment. This study, which was conducted by researchers from the University of Utah and the University of Buffalo, was published in the “Cancer Epidemiology” journal. Physicians recommend that first-degree relatives of individuals diagnosed with early onset colorectal cancer begin screening before they reach 50 years of age. This is mainly because cases of early onset colorectal cancer have increased considerably in the last few decades. The research suggests that early screening may benefit second- and third-degree relatives as well. First-degree relatives…

Continue Reading

TuesdayOct 12, 2021 1:31 pm

Research Finds That Costs Incurred by Neurology Patients Have Increased Significantly

New research has found that the costs for office visits and diagnostic tests for neurological conditions has increased significantly in the past decade or so. The research, which was reported in the American Academy of Neurology’s online issue of “Neurology,” discovered that individuals who registered for high-deductible health plans had higher chances of incurring higher costs than individuals on other plans. University of Michigan’s Chloe E. Hill, the author of the study, explained that this increase in costs could be harmful as it may prompt individuals to forgo diagnostic evaluation or leave those who complete their tests in financial strain…

Continue Reading

TuesdayOct 12, 2021 1:24 pm

AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) Among Leading Biotech Companies Innovating the Field of Early Cancer Screening and Detection

Blood and genomic testing are becoming preferable means of early cancer screening and detection Leaders innovating this niche of the medical industry include AnPac Bio, Grail, Thrive and Guardant AnPac Bio-Medical's testing features a database of more than 200,000 commercial and research multi-cancer test samples (probably the largest multi-cancer test data base) that detect up to 26 different types of cancer One of the few companies offering multi-cancer tests for risk assessment and actually contributing to the fight against cancer by having its high risk individuals (tested first by its tests and later) confirmed in the healthcare providers for cancer…

Continue Reading

TuesdayOct 12, 2021 11:32 am

RYAH Group Inc. (CSE: RYAH) Positioned to Impact Palliative Care with AI-Powered Plant-Based Solutions

Palliative care focuses on providing end-of-life care for chronically ill patients Preliminary research suggests cannabis relieves pain, appetite loss, anxiety  RYAH is the leader in volume-control technology for plant-based medicine RYAH’s ecosystem includes volume-control devices, medicine-carrying components, and AI-powered applications that capture and track data With a mission to advance remote-health solutions and analytics-based patient treatments across the world, RYAH Group (CSE: RYAH), the leader in volume-control technology for plant-based medicine, is positioned to address the urgent need for cannabis-based solutions in palliative care. Palliative care is an emerging healthcare field that focuses on providing solutions that alleviate the suffering…

Continue Reading

MondayOct 11, 2021 9:30 am

Why Timely Data Analysis Is Vital in Health Care

We have seen a lot of businesses go digital in the last year. Researchers believe that artificial intelligence (“AI”) will be useful in various areas, including the health-care sector. Studies have shown that more than 50% of health-care facilities don’t have a strategy on how to carry out analytics and govern data. This is because the sector still lacks a structured database from which data can be read, interpreted and applied to treatments in the future. With the ongoing pandemic, new approaches to predictive analytics, data analysis and health care are needed more than ever. Why is data analysis important…

Continue Reading

FridayOct 08, 2021 1:51 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Launch of New Website and Resources

Tryp Therapeutics recently launched a new website with updated resources to be featured on the site Over the next few weeks, the company will share key resources that will be the standout features of the new website Tryp believes that the new features represent expanded knowledge of the company’s strategy and will present more opportunities to existing investors and bring in more individuals who share in its course Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) has, since its inception, led the next wave of psychedelic drug development beyond mental health. Its focus on areas of high unmet medical needs and bring…

Continue Reading

FridayOct 08, 2021 11:44 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces New Executives, Internal Promotions

Cybin names Dr. Amir Inamdar as chief medical officer for European operations The company appoints Dr. Geoff Varty as head of research and development Both professionals bring decades of expertise to their new roles as Cybin focuses on progressing psychedelic therapeutics As Cybin (NEO: CYBN) (NYSE American: CYBN) continues its commitment to focus on the psychedelic therapeutic space and deliver proprietary drug-discovery platforms, the company has made key additions and changes (https://ibn.fm/0GBMQ). Most recently the company has appointed two new executives and announced internal promotions to continue strengthening its leadership team. Cybin has named Dr. Amir Inamdar as chief medical…

Continue Reading

FridayOct 08, 2021 10:17 am

Researchers Find Tool That Can Predict Risk of Secondary Cancer Development in Pediatric Cancer Survivors

A new study has discovered a tool that can identify cancer survivors who have syndromes that predispose them to cancer and heighten their risk of subsequent cancer development. The research, which was published in the “Journal of Clinical Oncology,” notes that the tool had proven to be effective in patients who hadn’t been exposed to radiation during treatment of their primary malignancies as well as in survivors of central nervous system tumors and solid tumors. The tool integrates the specific features of tumors as well as the family and clinical history of every patient and feeds them into the tumor-particular…

Continue Reading

ThursdayOct 07, 2021 9:30 am

Sobering Truth: Alcohol Behind More American Fatalities Compared to Drug Overdoses

In July, the Centers for Disease Control and Prevention released preliminary statistics which show that last year drug overdose deaths increased significantly, reaching 93,000. The opioid epidemic seems to be getting worse with each passing day, which is why it’s surprising to learn that alcohol kills more individuals in America than drug overdoses do. The National Institute on Alcohol Abuse and Alcoholism estimates that about 95,000 individuals succumb to alcohol-related causes every year. Given that September was national recovery month, the time is ripe to evaluate and recognize the extent of the country’s alcohol dependence and highlight ways to help…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000